இஞ்சி ஜூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இஞ்சி ஜூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இஞ்சி ஜூ Today - Breaking & Trending Today

Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute


Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute
News provided by
Share this article
Share this article
CHELMSFORD, Mass., Jan. 12, 2021 /PRNewswire/  Brooks Automation, Inc. (Nasdaq:BRKS)  announced today that GENEWIZ, the Company s genomics analysis business, has been awarded one of six  Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years. ....

United States , Steve Schwartz , John Mills , Sherry Dinsmore , National Cancer Institute , Genomic Data Analysis Network , National Institutes Of Health , Brooks Automation Inc , Company Life Sciences , Genome Characterization Center Indefinite Delivery Quantity , Brooks Automation , National Institutes , Cancer Genomics , Ginger Zhou , Biospecimen Core Resource , Genomic Data , Genome Characterization , Life Sciences , Life Science , North America , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீவ் ஸ்க்வார்ட்ஸ் , ஜான் ஆலைகள் , ஷெர்ரி டின்ஸ்மோர் , தேசிய புற்றுநோய் நிறுவனம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் ,

Dr. Loupy, French Transplant Physician and Researcher Awarded GENEWIZ Digital Spatial Profiler Grant


Share this article
Share this article
SOUTH PLAINFIELD, N.J., Jan. 7, 2021 /PRNewswire/ Leading global genomics service provider, GENEWIZ, a Brooks Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft rejection.
The success or failure of organ transplantation largely depends on rejection responses. Rejection accounts for most allograft failures worldwide, with immediate effects on patient mortality, morbidity –  presenting various complications for the patient health – and high societal costs. For nearly 30 years, the Banff Classification of Allograft Pathology has provided ....

United States , France General , United Kingdom , Lindsay Kendall Zuill , Blaise Robin , Alexandre Loupy , French National Medical Research Agency , Paris Transplant Group , Paris Transplant Group At Inserm , Genomics Services , Company Life Sciences , Expertise Center , Brooks Life Sciences Company , Necker Hospital , Spatial Profiler , Nanostring Technologies , Banff Classification , Allograft Pathology , Banff Kidney Meeting , Ginger Zhou , Vice President , Life Sciences , Brooks Life Science , North America , South Plainfield , French National Medical Research ,